Found in the first period, the immune system jumped higher than the second needle. But it rises very quickly, it falls very quickly within 8 weeks, while human research results are still in the observation period, we still have to wait.
Dr. Anan Chongkaewwatana, virologist Director of Animal Health and Management Innovation Research Group National Center for Genetic Engineering and Biotechnology (Biotech), National Science and Technology Development Agency (NSTDA) posted a message via Facebook on October 22, 64, stating “the principle of Immunologists say that when the third stimulation needle is injected, the antibody value rises. This is clear information. But the controversial question is Stimulate the third needle and the improved immunity will last a long time. Or did it fall later than what was found after the second needle? if stay longer Subsequent stimulation injections may not be necessary. Or wait for a long time. Right now, there is not much information on the level of immunity after the third injection in people. because it was in the waiting period after the immune system was ejected after the stimulation needle After a while, you’ll see a clear picture.
But the data tested in the monkeys previously tested The monkeys who received two doses of Moderna’s mRNA showed a steady decline in the background of the second dose but about 29 weeks after the first dose, or 5-6 weeks. month after second dose The landscape will fall about 10 times and when receiving the 3rd needle, the landscape will jump higher than when the second needle is expected. But the information that everyone wants to know is How long does the better landscape last? The resulting graph shows that Immune sensitivity came to near the level after the second dose within 8 weeks (2 months) after the 3rd dose stimulation, which came down quite quickly. If the graph plummets down to the original level Immune levels may fall to pre-stimulation levels faster than expected…but the research team did not continue to collect data. This is because research has first challenged monkeys with the virus to determine if the invasive immune system was sufficient to prevent infection. The level is not very low, so there should not be a problem with protection.
This information does not belong to people. The differences between monkeys and people may not be the same at all. Must bring information from people to compare whether the fourth needle may come faster or not.